Baby tamoxifen shows lasting protection against breast cancer in High-Risk women
NCT ID NCT06982313
First seen Feb 02, 2026 · Last updated May 20, 2026 · Updated 17 times
Summary
This study looks at the long-term effects of taking a low dose of tamoxifen (5 mg daily for 3 years) to prevent breast cancer from coming back in women who had early-stage breast changes or very small tumors. Researchers will follow about 1,500 women for many years to see how well the drug works and if it remains safe. The goal is to confirm that this gentler treatment can be a good option for preventing invasive breast cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER INVASIVE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Study site
Genova, Italy, 16145, Italy
-
E. O. Ospedali Galliera
Genoa, Italy
Conditions
Explore the condition pages connected to this study.